Years ago, we only had a couple of drugs for diabetes and we wanted more. Then, in the past 10 years, we have had an explosion of drugs and you can bet there are more coming soon. This week, Joy Pape sits down with Jeffery Emmick from Eli Lilly to …

Probiotic supplements may be considered as an adjunct treatment for glycemic control in women who are pregnant and have gestational diabetes.

Children of mothers with untreated gestational diabetes mellitus are at risk of insulin resistance and impairment in glucose metabolism.

In patients with stage 3 kidney disease, metformin use may be safe and may reduce the risk of mortality and cardiovascular events.

Jeffrey Emmick MD, Ph.D is the vice president of product development at Eli Lilly and Company. Dr. Emmick has been with the organization for over 20 years in various roles. Currently, he is responsible for late-stage clinical development for the entire Lilly diabetes portfolio.

Linkage studies identify regions of the genome that are shared more frequently than would be expected by chance by relatives affected by a particular disease. Most studies analyze affected sibling pairs and utilize genetic markers that are scattered throughout the genome at moderate density, typically microsatellites. A significant excess of allele sharing identical by-descent (IBD) in affected sibpairs suggests that the region containing the marker locus also contains a disease susceptibility locus. The first linkage scan for T1DM identified 20 chromosomal regions with suggestive evidence of linkage to disease, including the HLA and INS gene regions.

Improvement in HRQoL, fatigue for patients with persistent symptoms despite normal thyroid gland function